Indisulam (E7070)

Indisulam (E7070) is an inhibitor of Carbonic Anhydrase and CDK2 used in studies of Cell Cycle Regulation. It is especially relevant in cancer, cardiovascular, and cell cycle models, where defined compound exposure can be linked to checkpoint control, mitotic progression, and proliferation timing.

By inhibiting Carbonic Anhydrase and CDK2, Indisulam (E7070) can be used to examine checkpoint control, mitotic progression, and proliferation timing. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In cancer, cardiovascular, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Carbonic Anhydrase and CDK2
• Pathway perturbation studies connected to Cell Cycle Regulation
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, Indisulam (E7070) is appropriate when a defined chemical perturbant is needed to connect Carbonic Anhydrase and CDK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cardiovascular, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.